ArticleOncoTargets and therapy2017

NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy.

Boksoon Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.